All-in‐one vaccines (AAVs) are generally designed to be used as a last resort, but experts say that the “kids first” approach to the pandemic could be more effective.
“If you can prevent pandemic, then it’s all-inclusive, but if you have a vaccine, then you’re in the all-of-us, not in the kids first group,” said Dr. Rishi Prakash, associate director of the National Institute of Allergy and Infectious Diseases (NIAID).
Prakasu says the “all-ins” approach is more targeted, but the strategy can be adapted for other conditions.
“We have to do it in a way that’s scalable and effective and that’s the way to go,” Prakasa said.
“But I would argue that it would be easier to do that if we had a vaccine to address this issue than if we were trying to address it on the ground.”
Prakas’ colleague Dr. Mark Hulshof, associate professor of pediatrics at Boston Children’s Hospital, agrees that “kidsfirst” is more applicable.
“It’s a more comprehensive approach to this pandemic.
There are so many things that we can do, and there are so few resources that we have,” he said.
Hulschof added that there is no vaccine that can stop the spread of the virus, but there are vaccines that can make the immune system more robust.
“So I think that is the all in one approach that is most appropriate,” Hulschof said.
Prakassa says the best strategy is to vaccinate as many children as possible, but that this would likely not be possible without an AAV.
“The kids first approach is the only one that works,” he told CNN.
“That’s the only thing that is going to be effective.”